Document is current

Any future updates will be listed below

Selective JAK Inhibitor: Ritlecitinib

Crossref DOI link: https://doi.org/10.1007/978-3-031-84274-0_7

Published Online: 2025-05-06

Published Print: 2025

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark